AI medical imaging firm looks abroad after raising 100 mln yuan
Artificial intelligence (AI) medical imaging startup Imsight Medical Technology has completed another round of fundraising, this time led by China Merchants Innovation Investment Management, Chinese tech media 36Kr reports.
The company raised 20 million yuan (US$3.02 million) in a pre-series A funding led by Lenovo Capital and Incubator Group in 2017 and 60 million yuan in a series A round led by Shenzhen Capital Group in March.
Including the latest round, Imsight has raised 100 million yuan in total.
In an interview with the Hong Kong Economic Journal, the company reveals it now wants to focus on research and development of medical imaging products while continuing to explore clinical applications of its products. These efforts are seen as part of its goal to expand into overseas healthcare markets.
Founded in February 2017, Imsight is headquartered in Shenzhen, with R&D centers in Hong Kong, Chengdu and Beijing. Its team comes from the Medical Image Analysis Center at the Chinese University of Hong Kong (CUHK).
Professor Heng Pheng-ann, from the CUHK department of computer science and engineering, is one of the co-founders and the chief scientist of the startup.
Last year, the startup joined the Incu-Tech program run by the Hong Kong Science and Technology Parks Corporation. It currently focuses on developing deep learning technology for medical image analysis, which can ease the doctor's workload and enhance the accuracy of diagnosis.
Dr. Chen Hao, founder and co-chief executive of the company, said China has less than 10,000 registered pathologists, and a shortage of more than 100,000 doctors.
Medical imaging data in the country, including X-ray, computed tomography (CT) scan and magnetic resonance imaging (MRI) data, is growing at an average rate of 30 percent annually, according to Hao.
Such vast data, coupled with staff shortage, has led to a huge workload for doctors, he said. They have to constantly work overtime to maintain the operation of hospitals.
Take the diagnosis of lung cancer as an example. Doctors used to look closely at the CT scans of the lung with naked eyes, among many CT scan images, in order to spot tiny shadows representing affected areas. It takes about five minutes for each diagnosis; errors are bound to occur.
But with the help of AI algorithms, doctors can locate any lesion within 30 seconds.
The technology provided by Imsight now serves more than 5,000 patients each day. In order to prepare for overseas expansion, the company plans to build partnerships with 100 hospitals this year.
This article appeared in the Hong Kong Economic Journal on June 27
Translation by Jonathan Chong with additional reporting
– Contact us at [email protected]
JC/CG
-
Energising HK's creative industries through cultural big data Dr. Winnie Tang
The government has planned to allocate nearly HK$300 million for the development of Art Tech. How can the funding effectively improve the level of local culture and arts, and further consolidate Hong
-
How to well spend the HK$300 million allocated to art tech? Dr. Winnie Tang
Local movie director Chu Yuan passed away earlier. In a lament, film critic Ka Ming recalled Chu's five masterpieces in the 1960s and 1970s. In his remark, Ka criticised that like most old Hong Kong
-
A cross-border ‘yellow cow’ story Ben Kwok
Almost all overseas fellows of my age that I know came to Hong Kong during the pandemic only for one reason: to meet their parents as much as possible. But in order to see their parents in person,
-
Advancing responsible business conduct Hanscom Smith
We need only look at the front-page news to see that companies are reassessing their business practices in areas ranging from preventing and addressing forced labor in their supply chains,
-
Re-opening Hong Kong a must Brian YS Wong
Hong Kong’s value to its country remains its openness, cosmopolitanism, and fundamental willingness to embrace and take on the unknown. It is its internationalism, as opposed to inward-looking
